- Home
- LIEN vs JUNS Comparison
LIEN vs JUNS Comparison
Compare LIEN & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIEN
- JUNS
- Stock Information
- Founded
- LIEN 2021
- JUNS 2015
- Country
- LIEN United States
- JUNS United States
- Employees
- LIEN N/A
- JUNS N/A
- Industry
- LIEN
- JUNS
- Sector
- LIEN
- JUNS
- Exchange
- LIEN NYSE
- JUNS NYSE
- Market Cap
- LIEN 234.6M
- JUNS 17.6M
- IPO Year
- LIEN 2022
- JUNS 2024
- Fundamental
- Price
- LIEN $10.10
- JUNS $0.62
- Analyst Decision
- LIEN Hold
- JUNS
- Analyst Count
- LIEN 1
- JUNS 0
- Target Price
- LIEN N/A
- JUNS N/A
- AVG Volume (30 Days)
- LIEN 16.8K
- JUNS 103.2K
- Earning Date
- LIEN 05-14-2025
- JUNS 05-20-2025
- Dividend Yield
- LIEN 13.59%
- JUNS N/A
- EPS Growth
- LIEN N/A
- JUNS N/A
- EPS
- LIEN 0.93
- JUNS N/A
- Revenue
- LIEN $21,665,753.00
- JUNS N/A
- Revenue This Year
- LIEN $102.44
- JUNS N/A
- Revenue Next Year
- LIEN N/A
- JUNS N/A
- P/E Ratio
- LIEN $10.77
- JUNS N/A
- Revenue Growth
- LIEN 81.56
- JUNS N/A
- 52 Week Low
- LIEN $9.71
- JUNS $0.51
- 52 Week High
- LIEN $13.38
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- LIEN N/A
- JUNS N/A
- Support Level
- LIEN N/A
- JUNS N/A
- Resistance Level
- LIEN N/A
- JUNS N/A
- Average True Range (ATR)
- LIEN 0.00
- JUNS 0.00
- MACD
- LIEN 0.00
- JUNS 0.00
- Stochastic Oscillator
- LIEN 0.00
- JUNS 0.00
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company is an externally managed, closed-end, non-diversified management investment company with an investment objective to maximize risk-adjusted returns on equity for its stockholders by investing in direct loans to privately held middle-market companies, with a focus on cannabis companies.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.